Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
CorrigendaCorrigenda
Open Access

Corrigenda

Anticancer Research December 2024, 44 (12) 5591-5592; DOI: https://doi.org/10.21873/anticanres.17386
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Vol. 44, No. 5, page 2247, the authors list should read:

TAYLOR AMERY1, SHAADI TABATABAEI1, MAYA SONPATKI2, EVAN Y. YU3,4 and TOMASZ M. BEER1

Vol. 44, No. 5, page 2247, the affiliations list should read:

1Division of Medical Oncology, Oregon Health & Science University, Portland, OR, U.S.A.;

2Department of Microbiology, Oregon State University, Corvallis, OR, U.S.A.;

3Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA, U.S.A.;

4Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, U.S.A.

Vol. 44, No. 9, p. 3925, Figure 2 should read:

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Vol. 44, No. 9, p. 3926, Figure 3 should read:

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Vol. 44, No. 11, p. 4761, the 1st affiliation should read:

1University of Science and Technology of Hanoi, Vietnam Academy of Science and Technology, Hanoi, Vietnam;

Vol. 34, No. 9, p. 4906, Figure 3A should read:

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
  • Copyright © 2024 The Author(s). Published by the International Institute of Anticancer Research.

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

PreviousNext
Back to top

In this issue

Anticancer Research: 44 (12)
Anticancer Research
Vol. 44, Issue 12
December 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Corrigenda
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
8 + 11 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Corrigenda
Anticancer Research Dec 2024, 44 (12) 5591-5592; DOI: 10.21873/anticanres.17386

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Corrigenda
Anticancer Research Dec 2024, 44 (12) 5591-5592; DOI: 10.21873/anticanres.17386
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Corrigenda
  • Corrigenda
  • Corrigenda
Show more Corrigenda
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire